FAQ: What Does Clinically Inadvisable Mean in Upadacitinib’s Expanded UC and CD Indications?
Thank you to AbbVie for their support on this FAQ Video Module.In this FAQ video module, Jamie Brogan, APRN from the IBD Center at Northwestern Medicine, breaks down the October 2025 FDA label expansi...
3 Feb 3min
FAQ: How Do You Balance Systemic and Liver Directed Therapies in Patients With MASH?
Thank you to Madrigal for their support on this FAQ Video Module.In this FAQ video, Allysa Saggese, NP, reviews how clinicians can balance systemic and liver-directed therapies in the treatment of met...
27 Jan 2min
FAQ: What is the Relevance of Assessing Alcohol Consumption in Patients With MASH?
Thank you to Madrigal for their support on this FAQ Video Module.In this FAQ video, Alison Moe, PA-C, discusses how alcohol consumption impacts the evaluation and progression of metabolic dysfunction–...
20 Jan 5min
Medication Review: Resmetirom: Thyroid Hormone Receptor-β Agonism in MASH Treatment
Thank you to Madrigal for their support of this Medication Review Video Module.In this medication review module, Michelle Barnett, PA-C, provides an in-depth overview of resmetirom, the first FDA-appr...
13 Jan 4min
APP Roundtable: Approach To Starting Treatments in Patients With CHB
In this expert-led podcast discussion on hepatitis B management, Elizabeth Goacher, PA-C, from Duke University Medical Center and Allison Moser, NP, from RUSH University Medical Center break down what...
7 Jan 12min
APP Roundtable: Navigating Difficult Conversations in CHB
This in-depth conversation explores how advanced practice providers navigate some of the most challenging discussions in the care of patients living with chronic hepatitis B. Drawing from years of rea...
7 Jan 25min
APP Roundtable: Addressing Co-Morbidities in CHB
In this expert-led podcast discussion, Patrick Horne and HoChong Gilles explore the complex management of comorbidities in patients with chronic viral hepatitis, with a focus on hepatitis B, hepatitis...
6 Jan 19min
FAQ: What Role Do NITs Play in Risk Stratification & Patient Selection—& Balancing Patient History?
Thank you to Madrigal for your support on this FAQ Video Module.In this short FAQ video module, Patrick Horne, President of GHAPP and a nurse practitioner at the University of Florida, discusses the c...
6 Jan 1min
